× The Vanderbilt Television News Archive is currently closed to in-person research, but is still fulfilling loan requests. For the latest information about COVID-19 (coronavirus disease), visit vu.edu/coronavirus.
Search the Archive

Special (Slow-K / The FDA) #488149

NBC Evening News for Tuesday, Apr 06, 1976
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws. For any such use, please visit NBC NEWS Archives XPRESS.

(Studio) Congress cmtes. to investigate FDA (Food and Drug Administration) regulation of drugs.
REPORTER: Edwin Newman

(No location given) Slow-K is world's leading potassium supplement. Elderly and those with heart problems and high blood pressure take it. Some doctors feel Slow-K dangerous. FDA (Food and Drug Administration) criticized for relying on honesty of drug companies
REPORTER: Linda Ellerbee

(Summit, New Jersey) In 1965, Ciba-Geigy Pharmaceuticals test Slow K for 1st time. [Hd. American Ciba test unit, Dr. Gilbert McMAHAN - says monkeys got ulcers from Slow-K.] Company applied for Slow-K approval from FDA (Food and Drug Administration) after McMahan leaves Ciba. McMahan wrote FDA (Food and Drug Administration) with regard to monkey study. Without letter, FDA (Food and Drug Administration) would have relied on Ciba's information FDA (Food and Drug Administration) criticized for being unwilling to punish drug companies
REPORTER: Linda Ellerbee

(DC) In February 1973, Dr. DeVaughn Belton, head of FDA (Food and Drug Administration) cardio-remal division, asks that case of missing monkey study be turned over for prosecution of Ciba. Bureau of Drugs Director Richard Crout doesn't sign memo. [CROUT - says div. probably lost memo. Have had several examples of potential prosecutions which didn't go forward well.] Ciba not investigated. FDA criticized for being influenced by drug mfrs. In September 1973, FDA (Food and Drug Administration) staff reviews Slow-K. [FDA (Food and Drug Administration) medical ofr. Dr. Stanley CORTELL - cites his opposition to Slow-K. People can die from it; some patients have died in United Kingdom.] Chart shows who objected to and who approved Slow-K. FDA criticized for advisory cmtes.' rubberstamping FDA (Food and Drug Administration) executive decisions. On December 6, 1973, Crout takes Slow-K to advisory committee Committee votes to go along with Crout. Slow-K gets okay on April 25, 1975. Ciba spent $10 million getting drug to market 1/2 million Americans take it. Reports of ulcers and bleeding reported to FDA. 35 doctors call Slow-K dangerous in August article in "The Medical Letter." Senate committee to study Slow-K. FDA (Food and Drug Administration) warns Ciba to not withhold information in future, 3 years after monkey study withheld. FDA may require box warning on drug.
REPORTER: Linda Ellerbee

(Studio) Report is on way FDA (Food and Drug Administration) handled Slow-K, not an editorial statement.
REPORTER: Edwin Newman

Reporter(s):
Ellerbee, Linda;
Newman, Edwin
Duration:
00:06:10

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.